Global Home Testing Kits Market Overview

The Global Market for Home Testing Kits Estimated at USD 3.6 Billion In the Year 2022, Is Projected To Reach A Revised Size Of USD 5.9 Billion By 2030, Growing At A CAGR Of 6.31 % Over The Forecast Period 2023-2030.

At-home testing kits are testing instruments that allow people to perform tests at home and receive results within a minute. Health testing instruments include health monitoring equipment for regular checking and controlling the health of various diseased patients like diabetes, HIV, and other infectious diseases. It is more convenient and comfortable to perform the test at home by using home test kits. These kits are self-testing kits and are advanced versions of the fast, point-of-care test kits that were created for healthcare professionals. Manufacturers are designing the kits for the strategy of wellness and prevention, and management of acute as well as chronic disorders. The variety of home test kits available in the market such as HIV tests, pregnancy tests, diabetes, ovulation test, and infectious diseases such as malaria, COVID-19, and others. In recent years there is rising the use of self-help and do-it-yourself (DIY) test kits because of the convenience to use and rapid results which significantly drives the market of the home test kit.

Home Testing Kits Market

Market Dynamics And Factors For Home Testing Kits Market

Drivers:

Rising Adoption of The Home Testing Kits

Growing awareness among the people about several new products, so adoption of the home testing kits is increased is the key factor that helps the growth of the market. In the last few decades increasing the prevalence of chronic diseases like heart disease, and diabetes. For instance, Statista stated that in 2021 there were 537 million people suffering from diabetes worldwide.  Moreover, according to WHO in 2021, there were 1.5 million people who acquired HIV worldwide. Thus, among the people growing awareness about the prevention of diseases. It is not possible for every patient to visit the hospital every day for a check-up. Hence, they prefer home test kits for regular check-ups. The pandemic period brings a huge change in the demand for home test kits. Owing to several restrictions in place, peoples like to buy home test kits. Apart from this, home testing kits are easily available at every pharmacy including online as well as offline pharmacies. Thus, its adoption is increasing that supporting the growth of the market of home testing kits over the forecast periods.

Restraints:

Inaccuracy in Results Associated with Home Testing Kits

Home testing kits have various benefits but most peoples are always doubtful about the accuracy of the result is the key factor that restricts the market growth of home testing kits.

Home testing kits are easy to use and come at affordable prices and are used for monitoring various infectious diseases. But some of the kits show variations in the result, so peoples are confused and have not trust the result of the home testing kits. Thus. they like to prefer to visit hospitals or laboratories for tests instead of home tests which is hampering the growth of the home testing kit market.

Opportunity:

Opportunity in the Advanced Technologies

The latest technologies used in the making of medical products provide a lucrative opportunity for the home testing kit market. Artificial Intelligence, Machine learning has the most important role in the healthcare sector and have the ability to improve the safety of patients and administrative processes through their quicker and automated performance. Owing growing prevalence of various infectious diseases manufacturers and the government also increasing their investment in new products. For instance, DAM Health a medical diagnostic company launched a new home test kit in March 2022 to meet the demand of the pandemic. AI technology is used in these kits for rapid and accurate results. Thus, novel advanced technology offers a huge opportunity for the home testing kits market during the forecast periods.

Segmentation Analysis Of Home Testing Kits Market

By Test Type, the glucose test is expected to have the maximum share in the home testing kit market during the forecast periods. Owing to the growing prevalence of diabetes patients around the world. The following figure shows the prevalence of diabetes in the world in the selected countries as of 2021.

Thus, this is the growing prevalence of coronavirus infections, rising the demand for cassettes for testing. Moreover, cassettes are also used for pregnancy tests, and an increase in the number of women using home pregnancy test kits. Thus, the growing demand for cassettes for various tests supports the growth of the market over the forecast periods.

By Distribution Channels, online pharmacies are dominated the market share of home test kits. Owing to the growing prevalence of various infectious diseases, rising the trend of purchasing medicines online.  Apart from this increasing number of internet users in the world prefer online pharmacies for purchasing any medical products. For instance, according to Statista, in 2021 there were 4.9 billion people using the internet in the world. The products in online pharmacies are cost-effective as compared to the products in retail pharmacies and drug stores. Thus, increasing the number of peoples that uses online pharmacies for the purchase of home test kits support the growth of the market.

Regional Analysis Of Home Testing Kits Market

North America is expected to dominate the home testing kit market owing to high healthcare expenditure and rising awareness about the home testing kits benefits. Additionally, in the North American region growing prevalence of the diseases such as diabetes, heart disease, and other infectious diseases. For instance, according to the center for disease control and prevention, in 2021 there was 37.3 million Americans had diabetes and 96 million Americans had prediabetes. Moreover, the covid-19 cases in North America are also increased and people in this region use rapid antigen test kits. There are various home testing kits are available in the market for the detection of pregnancy. According to Statista, in Unites State in 2020, there were 7.92 million women who used home pregnancy tests. Thus, the growing awareness about home testing kit use and the rising number of infectious disease patients in this region that expected to increase the market of home testing kits in the North American region over the forecast period.

The Asia Pacific is the second dominant region in the home test kit market. This is due to the highest population base with the large prevalence of various infectious diseases. In the APAC region high number of people that suffering from diabetes. For instance, according to Statista, China is the country with which the highest number of diabetes population. The flowing diagram shows the growing number of diabetes patients from 2015 to 2021 in China

Apart from this, in Pakistan, there were 31% of the diabetes population in the same year. In this region covid-19 incidence cases also increased and peoples are more aware of the new healthcare products for diagnosis including home test kits. Thus, the demand for home testing kits is increased from the APAC region which increases the market of this region.

Europe has rapid growth in the home testing kit market owing to the high adoption of the new technology. European peoples are well-educated and are more open to accepting new technology. In recent years, the prevalence of chronic diseases in Europe is increased. For instance, Statista stated that there were 2.6 million people have diabetes in 2021 Italy. The incidence of coronavirus patients is also increasing in this region. In Europe, there were 246 million confirmed cases of the covid-19 from January 2020 to August 2022. Peoples in this region are more aware of the diagnosis of diseases and they use home care tests for regular check-ups that propel the growth of the market of this region.

Covid-19 Impact Analysis On Home Testing Kits Market

COVID-19 began in Wuhan (China) in December 2019 and has since rapidly grown around the globe. In terms of confirmed cases and reported deaths, the US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are among the countries that have been most severely impacted. Because of the lockdowns, travel restrictions, and business closures, COVID-19 has had an impact on the businesses and industries of numerous nations. The pandemic had led to positive growth in home testing kits. Due to lockdown, stay-at-home orders, social distancing, and other government regulations people avoided visiting hospitals. Thus, sudden growth in the demand for the home testing kits such as thermometers, and a glucometer. The manufacturers are more invested in-home testing kits. After the pandemic, its demand is still continuously increasing which helps the growth of the home testing kit market in the forecast period.

Top Key Players Covered In Home Testing Kits Market

  • Abbott(US)
  • ACON Laboratories Inc. (US)
  • Rapikit (US)
  • BTNX INC. (Canada)
  • bioLytical Laboratories Inc. (Canada)
  • OraSure Technologies Inc. (USA)
  • BD (US)
  • Cardinal Health (USA)
  • B. Braun Melsungen AG (Germany)
  • Piramal Enterprises Ltd. (India)
  • PRIMA Lab SA (Switzerland)
  • Siemens Healthcare GmbH (Germany)
  • Quidel Corporation (California)
  • Bionime Corporation (California)
  • SA Scientific (US)
  • ARKRAY USA Inc. (USA)
  • Everlywell Inc. (US)
  • Nova Biomedical (Waltham, MA)
  • Eurofins Viracor Inc. (US)
  • SelfDiagnostics OU (Estonia)
  • AdvaCare Pharma (Shanghai)
  • AccuBio Tech Co. Ltd (China)
  • BioSure (UK)
  • Atlas Medical (UK)
  • TaiDoc Technology Corporation (Taiwan)
  • LifeScan IP Holdings LLC (Switzerland)
  • Chembio Diagnostics Inc. (US)
  • Drägerwerk AG & Co. KGaA (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland), and other major players.

Key Industry Development In The Home Testing Kits Market

In July 2021, Abbott, a medical device company launched covid-19 home test kits in India for the detection of symptomatic or asymptomatic SARS-COV-2 virus. Panbio Covid-19 is the name of this new kit.

In November 2020, the US Food and Drug Administration authorized the first covid-19 test kit for self-testing at home. The name of the kit is Lucira COVID-19 All-In-One Test Kit test is a molecular single-use test that detects the coronavirus.

Global Home Testing Kits Market

Base Year:

2022

Forecast Period:

2023 -2030

Historical Data :

2017 to 2022

Market Size in 2022:

USD 3.6 Bn.

Forecast Period 2023-30 CAGR:

6.31 %

Market Size in 2030:

USD 5.9 Bn.

Segments Covered:

By Test Type

  • Pregnancy Test
  • HIV Test Kit
  • Infectious Diseases
  • Glucose Tests
  • Others

By Product Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  •  Others

By Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Rising Adoption of The Home Testing Kits

Key Market Restraints:

  • Inaccuracy in Results Associated with Home Testing Kits

Key Opportunities:

  • Opportunity in the Advanced Technologies

Companies Covered in the report:

  • Abbott (US), ACON Laboratories Inc. (US), Rapikit (US), BTNX INC. (Canada), bioLytical Laboratories Inc. (Canada), and Other major players.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Home Testing Kits Market by Type
 5.1 Home Testing Kits Market Overview Snapshot and Growth Engine
 5.2 Home Testing Kits Market Overview
 5.3 Comprehensive Coverage
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Comprehensive Coverage: Geographic Segmentation
 5.4 Dwelling Coverage
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Dwelling Coverage: Geographic Segmentation
 5.5 Content Coverage
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Content Coverage: Geographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation

Chapter 6: Home Testing Kits Market by Application
 6.1 Home Testing Kits Market Overview Snapshot and Growth Engine
 6.2 Home Testing Kits Market Overview
 6.3 Personal
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Personal: Geographic Segmentation
 6.4 Enterprise
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Enterprise: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Home Testing Kits Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Ansoff Matrix
  7.1.5 Home Testing Kits Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Home Testing Kits Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 ABBOTT
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ACON LABORATORIES INC.
 7.4 RAPIKIT
 7.5 BTNX INC.
 7.6 BIOLYTICAL LABORATORIES INC.
 7.7 ORASURE TECHNOLOGIES INC.
 7.8 BD
 7.9 CARDINAL HEALTH
 7.10 B. BRAUN MELSUNGEN AG
 7.11 PIRAMAL ENTERPRISES LTD.
 7.12 PRIMA LAB SA
 7.13 SIEMENS HEALTHCARE GMBH
 7.14 QUIDEL CORPORATION
 7.15 BIONIME CORPORATION
 7.16 SA SCIENTIFIC
 7.17 ARKRAY USA INC.
 7.18 EVERLYWELL INC.
 7.19 NOVA BIOMEDICAL
 7.20 EUROFINS VIRACOR INC.
 7.21 SELFDIAGNOSTICS OU
 7.22 ADVACARE PHARMA
 7.23 ACCUBIO TECH CO. LTD
 7.24 BIOSURE
 7.25 ATLAS MEDICAL
 7.26 TAIDOC TECHNOLOGY CORPORATION
 7.27 LIFESCAN IP HOLDINGS LLC
 7.28 CHEMBIO DIAGNOSTICS INC.
 7.29 DRÄGERWERK AG & CO. KGAA
 7.30 F. HOFFMANN-LA ROCHE LTD.
 7.31 OTHER MAJOR PLAYERS

Chapter 8: Global Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Comprehensive Coverage
  8.2.2 Dwelling Coverage
  8.2.3 Content Coverage
  8.2.4 Others
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Personal
  8.3.2 Enterprise

Chapter 9: North America Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Comprehensive Coverage
  9.4.2 Dwelling Coverage
  9.4.3 Content Coverage
  9.4.4 Others
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Personal
  9.5.2 Enterprise
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Comprehensive Coverage
  10.4.2 Dwelling Coverage
  10.4.3 Content Coverage
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Personal
  10.5.2 Enterprise
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Comprehensive Coverage
  11.4.2 Dwelling Coverage
  11.4.3 Content Coverage
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Personal
  11.5.2 Enterprise
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Comprehensive Coverage
  12.4.2 Dwelling Coverage
  12.4.3 Content Coverage
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Personal
  12.5.2 Enterprise
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Home Testing Kits Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Comprehensive Coverage
  13.4.2 Dwelling Coverage
  13.4.3 Content Coverage
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Personal
  13.5.2 Enterprise
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

Global Home Testing Kits Market

Base Year:

2022

Forecast Period:

2023 -2030

Historical Data :

2017 to 2022

Market Size in 2022:

USD 3.6 Bn.

Forecast Period 2023-30 CAGR:

6.31 %

Market Size in 2030:

USD 5.9 Bn.

Segments Covered:

By Test Type

  • Pregnancy Test
  • HIV Test Kit
  • Infectious Diseases
  • Glucose Tests
  • Others

By Product Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  •  Others

By Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Rising Adoption of The Home Testing Kits

Key Market Restraints:

  • Inaccuracy in Results Associated with Home Testing Kits

Key Opportunities:

  • Opportunity in the Advanced Technologies

Companies Covered in the report:

  • Abbott (US), ACON Laboratories Inc. (US), Rapikit (US), BTNX INC. (Canada), bioLytical Laboratories Inc. (Canada), and Other major players.

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. HOME TESTING KITS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. HOME TESTING KITS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. HOME TESTING KITS MARKET COMPETITIVE RIVALRY
TABLE 005. HOME TESTING KITS MARKET THREAT OF NEW ENTRANTS
TABLE 006. HOME TESTING KITS MARKET THREAT OF SUBSTITUTES
TABLE 007. HOME TESTING KITS MARKET BY TYPE
TABLE 008. COMPREHENSIVE COVERAGE MARKET OVERVIEW (2016-2028)
TABLE 009. DWELLING COVERAGE MARKET OVERVIEW (2016-2028)
TABLE 010. CONTENT COVERAGE MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. HOME TESTING KITS MARKET BY APPLICATION
TABLE 013. PERSONAL MARKET OVERVIEW (2016-2028)
TABLE 014. ENTERPRISE MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA HOME TESTING KITS MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA HOME TESTING KITS MARKET, BY APPLICATION (2016-2028)
TABLE 017. N HOME TESTING KITS MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE HOME TESTING KITS MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE HOME TESTING KITS MARKET, BY APPLICATION (2016-2028)
TABLE 020. HOME TESTING KITS MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC HOME TESTING KITS MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC HOME TESTING KITS MARKET, BY APPLICATION (2016-2028)
TABLE 023. HOME TESTING KITS MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA HOME TESTING KITS MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA HOME TESTING KITS MARKET, BY APPLICATION (2016-2028)
TABLE 026. HOME TESTING KITS MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA HOME TESTING KITS MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA HOME TESTING KITS MARKET, BY APPLICATION (2016-2028)
TABLE 029. HOME TESTING KITS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ABBOTT: SNAPSHOT
TABLE 031. ABBOTT: BUSINESS PERFORMANCE
TABLE 032. ABBOTT: PRODUCT PORTFOLIO
TABLE 033. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. ACON LABORATORIES INC.: SNAPSHOT
TABLE 034. ACON LABORATORIES INC.: BUSINESS PERFORMANCE
TABLE 035. ACON LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 036. ACON LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. RAPIKIT: SNAPSHOT
TABLE 037. RAPIKIT: BUSINESS PERFORMANCE
TABLE 038. RAPIKIT: PRODUCT PORTFOLIO
TABLE 039. RAPIKIT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. BTNX INC.: SNAPSHOT
TABLE 040. BTNX INC.: BUSINESS PERFORMANCE
TABLE 041. BTNX INC.: PRODUCT PORTFOLIO
TABLE 042. BTNX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. BIOLYTICAL LABORATORIES INC.: SNAPSHOT
TABLE 043. BIOLYTICAL LABORATORIES INC.: BUSINESS PERFORMANCE
TABLE 044. BIOLYTICAL LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 045. BIOLYTICAL LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. ORASURE TECHNOLOGIES INC.: SNAPSHOT
TABLE 046. ORASURE TECHNOLOGIES INC.: BUSINESS PERFORMANCE
TABLE 047. ORASURE TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 048. ORASURE TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. BD: SNAPSHOT
TABLE 049. BD: BUSINESS PERFORMANCE
TABLE 050. BD: PRODUCT PORTFOLIO
TABLE 051. BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. CARDINAL HEALTH: SNAPSHOT
TABLE 052. CARDINAL HEALTH: BUSINESS PERFORMANCE
TABLE 053. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 054. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. B. BRAUN MELSUNGEN AG: SNAPSHOT
TABLE 055. B. BRAUN MELSUNGEN AG: BUSINESS PERFORMANCE
TABLE 056. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 057. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. PIRAMAL ENTERPRISES LTD.: SNAPSHOT
TABLE 058. PIRAMAL ENTERPRISES LTD.: BUSINESS PERFORMANCE
TABLE 059. PIRAMAL ENTERPRISES LTD.: PRODUCT PORTFOLIO
TABLE 060. PIRAMAL ENTERPRISES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. PRIMA LAB SA: SNAPSHOT
TABLE 061. PRIMA LAB SA: BUSINESS PERFORMANCE
TABLE 062. PRIMA LAB SA: PRODUCT PORTFOLIO
TABLE 063. PRIMA LAB SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. SIEMENS HEALTHCARE GMBH: SNAPSHOT
TABLE 064. SIEMENS HEALTHCARE GMBH: BUSINESS PERFORMANCE
TABLE 065. SIEMENS HEALTHCARE GMBH: PRODUCT PORTFOLIO
TABLE 066. SIEMENS HEALTHCARE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. QUIDEL CORPORATION: SNAPSHOT
TABLE 067. QUIDEL CORPORATION: BUSINESS PERFORMANCE
TABLE 068. QUIDEL CORPORATION: PRODUCT PORTFOLIO
TABLE 069. QUIDEL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. BIONIME CORPORATION: SNAPSHOT
TABLE 070. BIONIME CORPORATION: BUSINESS PERFORMANCE
TABLE 071. BIONIME CORPORATION: PRODUCT PORTFOLIO
TABLE 072. BIONIME CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. SA SCIENTIFIC: SNAPSHOT
TABLE 073. SA SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 074. SA SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 075. SA SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. ARKRAY USA INC.: SNAPSHOT
TABLE 076. ARKRAY USA INC.: BUSINESS PERFORMANCE
TABLE 077. ARKRAY USA INC.: PRODUCT PORTFOLIO
TABLE 078. ARKRAY USA INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. EVERLYWELL INC.: SNAPSHOT
TABLE 079. EVERLYWELL INC.: BUSINESS PERFORMANCE
TABLE 080. EVERLYWELL INC.: PRODUCT PORTFOLIO
TABLE 081. EVERLYWELL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. NOVA BIOMEDICAL: SNAPSHOT
TABLE 082. NOVA BIOMEDICAL: BUSINESS PERFORMANCE
TABLE 083. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 084. NOVA BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. EUROFINS VIRACOR INC.: SNAPSHOT
TABLE 085. EUROFINS VIRACOR INC.: BUSINESS PERFORMANCE
TABLE 086. EUROFINS VIRACOR INC.: PRODUCT PORTFOLIO
TABLE 087. EUROFINS VIRACOR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. SELFDIAGNOSTICS OU: SNAPSHOT
TABLE 088. SELFDIAGNOSTICS OU: BUSINESS PERFORMANCE
TABLE 089. SELFDIAGNOSTICS OU: PRODUCT PORTFOLIO
TABLE 090. SELFDIAGNOSTICS OU: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. ADVACARE PHARMA: SNAPSHOT
TABLE 091. ADVACARE PHARMA: BUSINESS PERFORMANCE
TABLE 092. ADVACARE PHARMA: PRODUCT PORTFOLIO
TABLE 093. ADVACARE PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. ACCUBIO TECH CO. LTD: SNAPSHOT
TABLE 094. ACCUBIO TECH CO. LTD: BUSINESS PERFORMANCE
TABLE 095. ACCUBIO TECH CO. LTD: PRODUCT PORTFOLIO
TABLE 096. ACCUBIO TECH CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 096. BIOSURE: SNAPSHOT
TABLE 097. BIOSURE: BUSINESS PERFORMANCE
TABLE 098. BIOSURE: PRODUCT PORTFOLIO
TABLE 099. BIOSURE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 099. ATLAS MEDICAL: SNAPSHOT
TABLE 100. ATLAS MEDICAL: BUSINESS PERFORMANCE
TABLE 101. ATLAS MEDICAL: PRODUCT PORTFOLIO
TABLE 102. ATLAS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102. TAIDOC TECHNOLOGY CORPORATION: SNAPSHOT
TABLE 103. TAIDOC TECHNOLOGY CORPORATION: BUSINESS PERFORMANCE
TABLE 104. TAIDOC TECHNOLOGY CORPORATION: PRODUCT PORTFOLIO
TABLE 105. TAIDOC TECHNOLOGY CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. LIFESCAN IP HOLDINGS LLC: SNAPSHOT
TABLE 106. LIFESCAN IP HOLDINGS LLC: BUSINESS PERFORMANCE
TABLE 107. LIFESCAN IP HOLDINGS LLC: PRODUCT PORTFOLIO
TABLE 108. LIFESCAN IP HOLDINGS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. CHEMBIO DIAGNOSTICS INC.: SNAPSHOT
TABLE 109. CHEMBIO DIAGNOSTICS INC.: BUSINESS PERFORMANCE
TABLE 110. CHEMBIO DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 111. CHEMBIO DIAGNOSTICS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. DRÄGERWERK AG & CO. KGAA: SNAPSHOT
TABLE 112. DRÄGERWERK AG & CO. KGAA: BUSINESS PERFORMANCE
TABLE 113. DRÄGERWERK AG & CO. KGAA: PRODUCT PORTFOLIO
TABLE 114. DRÄGERWERK AG & CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. F. HOFFMANN-LA ROCHE LTD.: SNAPSHOT
TABLE 115. F. HOFFMANN-LA ROCHE LTD.: BUSINESS PERFORMANCE
TABLE 116. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 117. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 118. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 119. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 120. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. HOME TESTING KITS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. HOME TESTING KITS MARKET OVERVIEW BY TYPE
FIGURE 012. COMPREHENSIVE COVERAGE MARKET OVERVIEW (2016-2028)
FIGURE 013. DWELLING COVERAGE MARKET OVERVIEW (2016-2028)
FIGURE 014. CONTENT COVERAGE MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. HOME TESTING KITS MARKET OVERVIEW BY APPLICATION
FIGURE 017. PERSONAL MARKET OVERVIEW (2016-2028)
FIGURE 018. ENTERPRISE MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA HOME TESTING KITS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE HOME TESTING KITS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC HOME TESTING KITS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA HOME TESTING KITS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA HOME TESTING KITS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be forecast period in the Home Testing Kits Market research report?

The forecast period in the Home Testing Kits Market research report is 2023-2030.

Who are the key players in Home Testing Kits Market?

Abbott (US), ACON Laboratories Inc. (US), Rapikit (US),  BTNX INC. (Canada), bioLytical Laboratories Inc. (Canada), OraSure Technologies Inc. (USA), BD (US), Cardinal Health (USA), B. Braun Melsungen AG (Germany),             Piramal Enterprises Ltd. (India), PRIMA Lab SA (Switzerland), Siemens Healthcare GmbH (Germany), Quidel Corporation (California), Bionime Corporation (California), SA Scientific (US), ARKRAY USA Inc. (USA), Everlywell Inc. (US), Nova Biomedical (Waltham, MA), Eurofins Viracor Inc. (US),   SelfDiagnostics OU (Estonia), AdvaCare Pharma (Shanghai), AccuBio Tech Co. Ltd (China), BioSure (UK), Atlas Medical (UK), TaiDoc Technology Corporation (Taiwan), LifeScan IP Holdings LLC (Switzerland), Chembio Diagnostics Inc. (US), Drägerwerk AG & Co. KGaA (Germany), F. Hoffmann-La Roche Ltd.( Switzerland), and other major players.

What are the segments of the Home Testing Kits Market?

The Home Testing Kits Market is segmented into Test Type, Product Type, Distribution Channels, and region. By Test type, the market is categorized into Pregnancy Tests, HIV Test kits, Infectious Diseases, Glucose Tests, and Others. By Product Type, the market is categorized into Cassette, Strip, Midstream, Test Panel, and Others. By Distribution Channels, the market is categorized into Retail Pharmacies, Drug Stores, Supermarkets/hypermarkets, and Online Pharmacies. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).

What is the Home Testing Kits Market?

At-home testing kits are testing instruments that allow people to perform tests at home and receive results within a minute. Health testing instruments include health monitoring equipment for regular checking and controlling the health of various diseased patients like diabetes, HIV, and other infectious diseases.

How big is the Home Testing Kits Market?

The Global Market for Home Testing Kits Estimated at USD 3.6 Billion In the Year 2022, Is Projected To Reach A Revised Size Of USD 5.9 Billion By 2030, Growing At A CAGR Of 6.31 % Over The Forecast Period 2023-2030.